These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39177013)

  • 21. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study.
    Kuten-Shorrer M; Treister NS; Stock S; Kelley JM; Ji YD; Woo SB; Lerman MA; Palmason S; Sonis ST; Villa A
    J Oral Facial Pain Headache; 2017 Summer; 31(3):257-263. PubMed ID: 28738111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of xerostomia in burning mouth syndrome: a case-control study.
    Silva LA; Siqueira JT; Teixeira MJ; Siqueira SR
    Arq Neuropsiquiatr; 2014 Feb; 72(2):91-8. PubMed ID: 24604360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of amitriptyline for treatment of somatoform pain disorder in the orofacial region: A case series.
    Ikawa M; Yamada K; Ikeuchi S
    J Orofac Pain; 2006; 20(3):234-40. PubMed ID: 16913433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.
    Mercadante S; Arcuri E; Tirelli W; Villari P; Casuccio A
    Tumori; 2002; 88(3):239-42. PubMed ID: 12195763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort.
    Poterucha TJ; Murphy SL; Rho RH; Sandroni P; Warndahl RA; Weiss WT; Davis MD
    Pain Physician; 2012; 15(6):485-8. PubMed ID: 23159965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a 2% topical chamomile application for treating burning mouth syndrome: a controlled clinical trial.
    Valenzuela S; Pons-Fuster A; López-Jornet P
    J Oral Pathol Med; 2016 Aug; 45(7):528-33. PubMed ID: 26694632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amitriptyline for neuropathic pain and fibromyalgia in adults.
    Moore RA; Derry S; Aldington D; Cole P; Wiffen PJ
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008242. PubMed ID: 23235657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies.
    Rossignol J; Cozzi B; Liebaert F; Hatton S; Viallard ML; Hermine O; Greco C
    Support Care Cancer; 2019 Aug; 27(8):3053-3059. PubMed ID: 30607681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amitriptyline for neuropathic pain in adults.
    Moore RA; Derry S; Aldington D; Cole P; Wiffen PJ
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD008242. PubMed ID: 26146793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids for fibromyalgia.
    Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study.
    Uzaraga I; Gerbis B; Holwerda E; Gillis D; Wai E
    Support Care Cancer; 2012 Jul; 20(7):1515-24. PubMed ID: 21847539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study.
    Amos K; Yeoh SC; Farah CS
    J Orofac Pain; 2011; 25(2):125-30. PubMed ID: 21528119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions for the treatment of burning mouth syndrome.
    Zakrzewska JM; Glenny AM; Forssell H
    Cochrane Database Syst Rev; 2001; (3):CD002779. PubMed ID: 11687027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy.
    Dinat N; Marinda E; Moch S; Rice AS; Kamerman PR
    PLoS One; 2015; 10(5):e0126297. PubMed ID: 25974287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study: alleviation of pain in burning mouth syndrome with topical sucralose.
    Hirsch AR; Ziad A; Kim AY; Lail NS; Sharma S
    Headache; 2011 Mar; 51(3):444-446. PubMed ID: 21352218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Grushka M; Epstein J; Mott A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):557-61. PubMed ID: 9830647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of treatment for patients with burning mouth syndrome.
    Tan HL; Smith JG; Hoffmann J; Renton T
    Cephalalgia; 2022 Feb; 42(2):128-161. PubMed ID: 34404247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.